ES2097093A1 - Nuevos compuestos derivados de 5h-tiazolo (3,2-a) pirimidin-5-ona. - Google Patents

Nuevos compuestos derivados de 5h-tiazolo (3,2-a) pirimidin-5-ona.

Info

Publication number
ES2097093A1
ES2097093A1 ES09501029A ES9501029A ES2097093A1 ES 2097093 A1 ES2097093 A1 ES 2097093A1 ES 09501029 A ES09501029 A ES 09501029A ES 9501029 A ES9501029 A ES 9501029A ES 2097093 A1 ES2097093 A1 ES 2097093A1
Authority
ES
Spain
Prior art keywords
thiazolo
pyrimidin
derivatives
carbon atoms
methylendioxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09501029A
Other languages
English (en)
Other versions
ES2097093B1 (es
Inventor
Ambros Rafael Foguet
Burniol Lluis Anglada
Hernandez Jose A Ortiz
Munoz Aurelio Sacristan
Barenys Josep M Castello
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferrer Internacional SA
Original Assignee
Ferrer Internacional SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Internacional SA filed Critical Ferrer Internacional SA
Priority to ES09501029A priority Critical patent/ES2097093B1/es
Priority to TW085105655A priority patent/TW430666B/zh
Priority to IL11828096A priority patent/IL118280A/xx
Priority to ZA964091A priority patent/ZA964091B/xx
Priority to MX9601953A priority patent/MX9601953A/es
Priority to PT96919807T priority patent/PT773947E/pt
Priority to JP8535401A priority patent/JPH10503782A/ja
Priority to AU58203/96A priority patent/AU698455B2/en
Priority to NZ308533A priority patent/NZ308533A/en
Priority to PCT/EP1996/002254 priority patent/WO1996037498A1/en
Priority to CA002195578A priority patent/CA2195578A1/en
Priority to DK96919807T priority patent/DK0773947T3/da
Priority to US08/765,935 priority patent/US5798361A/en
Priority to DE69610477T priority patent/DE69610477T2/de
Priority to AT96919807T priority patent/ATE196633T1/de
Priority to EP96919807A priority patent/EP0773947B1/en
Priority to NO970327A priority patent/NO308304B1/no
Publication of ES2097093A1 publication Critical patent/ES2097093A1/es
Application granted granted Critical
Publication of ES2097093B1 publication Critical patent/ES2097093B1/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

NUEVOS COMPUESTOS DERIVADOS DE 5H-TIAZOLO[3,2-A]PIRIMIDIN-5-ONA DE FORMULA GENERAL (I): *FIG* DONDE AR ES UN RESTO FENIL OPCIONALMENTE SUSTITUIDO POR UNO O DOS GRUPOS ELEGIDOS ENTRE HALOGENO, ALQUIL CUYO NUMERO DE ATOMOS DE CARBONO ESTA COMPRENDIDO ENTRE 1 Y 4, METILENDIOXI, ALCOXI CUYO NUMERO DE ATOMOS DE CARBONO ESTA COMPRENDIDO ENTRE 1 Y 4, Y TRIFLUOROMETIL; Y R ES UN RESTO ELEGIDO ENTRE (A) O (B): ASI COMO SUS SALES DE ADICION FARMACEUTICAMENTE ACEPTABLES. LA PRESENTE INVENCION TAMBIEN DESCRIBE PROCEDIMIENTOS E INTERMEDIOS PARA SU OBTENCION Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN.
ES09501029A 1995-05-26 1995-05-26 Nuevos compuestos derivados de 5h-tiazolo (3,2-a) pirimidin-5-ona. Expired - Lifetime ES2097093B1 (es)

Priority Applications (17)

Application Number Priority Date Filing Date Title
ES09501029A ES2097093B1 (es) 1995-05-26 1995-05-26 Nuevos compuestos derivados de 5h-tiazolo (3,2-a) pirimidin-5-ona.
TW085105655A TW430666B (en) 1995-05-26 1996-05-14 New 5H-thiazolo[3,2-a]pyrimidin-5-one derivatives
IL11828096A IL118280A (en) 1995-05-26 1996-05-15 7-Methyl-3-phenyl-6-[2-(4-substituted-1-piperidinyl) ethyl]-5h-thiazolo [3,2-a]pyrimidin-5-one d erivatives their preparation and pharmaceutical compositions containing them
ZA964091A ZA964091B (en) 1995-05-26 1996-05-22 5H-thiazolo[3,2-a]pyrimidin-5-one derivatives
MX9601953A MX9601953A (es) 1995-05-26 1996-05-23 Nuevo compesto derivados de 5h-tiazolo [3,2-a] pirimidin-5-ona.
AT96919807T ATE196633T1 (de) 1995-05-26 1996-05-24 5h- thiazolo(3,2-a)pyrimidin-5-on-derivate
AU58203/96A AU698455B2 (en) 1995-05-26 1996-05-24 5H-thiazolo{3,2-a}pyrimidin-5-one derivatives
NZ308533A NZ308533A (en) 1995-05-26 1996-05-24 Phenyl substituted 5h-[3,2-a]pyrimidin-5-one derivatives and pharmaceutical compositions
PT96919807T PT773947E (pt) 1995-05-26 1996-05-24 Derivados de 5h-tiazolo ¬3,2-a| pirimidin-5-ona
CA002195578A CA2195578A1 (en) 1995-05-26 1996-05-24 5h-thiazolo[3,2-a]pyrimidin-5-one derivatives
DK96919807T DK0773947T3 (da) 1995-05-26 1996-05-24 5H-thiazolo[3,2-a]pyrimidin-5-on-derivater
US08/765,935 US5798361A (en) 1995-05-26 1996-05-24 5H-thiazolo 3,2-a!pyrimidin-5-one derivatives
DE69610477T DE69610477T2 (de) 1995-05-26 1996-05-24 5H- THIAZOLO(3,2-a)PYRIMIDIN-5-ON-DERIVATE
JP8535401A JPH10503782A (ja) 1995-05-26 1996-05-24 新規な５Ｈ−チアゾロ［３，２−ａ］ピリミジン−５−オン誘導体
EP96919807A EP0773947B1 (en) 1995-05-26 1996-05-24 5H-THIAZOLO 3,2-a]PYRIMIDIN-5-ONE DERIVATIVES
PCT/EP1996/002254 WO1996037498A1 (en) 1995-05-26 1996-05-24 5H-THIAZOLO[3,2-a]PYRIMIDIN-5-ONE DERIVATIVES
NO970327A NO308304B1 (no) 1995-05-26 1997-01-24 Nye 5H-thiazol[3,2-a]pyrimidin-5-on derivater, anvendelse derav for fremstilling av farmasøytiske sammensetninger, farmasøytiske sammensetninger inneholdende derivatene, samt et preparat til behandling av psykose, schizofreni og angst

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09501029A ES2097093B1 (es) 1995-05-26 1995-05-26 Nuevos compuestos derivados de 5h-tiazolo (3,2-a) pirimidin-5-ona.

Publications (2)

Publication Number Publication Date
ES2097093A1 true ES2097093A1 (es) 1997-03-16
ES2097093B1 ES2097093B1 (es) 1998-01-16

Family

ID=8290506

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09501029A Expired - Lifetime ES2097093B1 (es) 1995-05-26 1995-05-26 Nuevos compuestos derivados de 5h-tiazolo (3,2-a) pirimidin-5-ona.

Country Status (17)

Country Link
US (1) US5798361A (es)
EP (1) EP0773947B1 (es)
JP (1) JPH10503782A (es)
AT (1) ATE196633T1 (es)
AU (1) AU698455B2 (es)
CA (1) CA2195578A1 (es)
DE (1) DE69610477T2 (es)
DK (1) DK0773947T3 (es)
ES (1) ES2097093B1 (es)
IL (1) IL118280A (es)
MX (1) MX9601953A (es)
NO (1) NO308304B1 (es)
NZ (1) NZ308533A (es)
PT (1) PT773947E (es)
TW (1) TW430666B (es)
WO (1) WO1996037498A1 (es)
ZA (1) ZA964091B (es)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0070053A2 (en) * 1981-07-15 1983-01-19 Janssen Pharmaceutica N.V. Novel bicyclic pyrimidin-5-one derivatives
EP0196132A2 (en) * 1985-03-27 1986-10-01 Janssen Pharmaceutica N.V. 1,2-Benzisoxazol-3-yl and 1,2-benzisothiazol-3-yl derivatives
WO1994001437A1 (en) * 1992-07-13 1994-01-20 Janssen Pharmaceutica N.V. Novel 4-(3-benzofuranyl)piperidinyl and 4-(3-benzothienyl)piperidinyl derivatives and pharmaceutical compositions containing them

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0070053A2 (en) * 1981-07-15 1983-01-19 Janssen Pharmaceutica N.V. Novel bicyclic pyrimidin-5-one derivatives
EP0196132A2 (en) * 1985-03-27 1986-10-01 Janssen Pharmaceutica N.V. 1,2-Benzisoxazol-3-yl and 1,2-benzisothiazol-3-yl derivatives
WO1994001437A1 (en) * 1992-07-13 1994-01-20 Janssen Pharmaceutica N.V. Novel 4-(3-benzofuranyl)piperidinyl and 4-(3-benzothienyl)piperidinyl derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
JPH10503782A (ja) 1998-04-07
NO970327L (no) 1997-01-24
PT773947E (pt) 2001-01-31
IL118280A0 (en) 1996-09-12
EP0773947B1 (en) 2000-09-27
NO308304B1 (no) 2000-08-28
NZ308533A (en) 1997-11-24
AU5820396A (en) 1996-12-11
TW430666B (en) 2001-04-21
ATE196633T1 (de) 2000-10-15
US5798361A (en) 1998-08-25
DK0773947T3 (da) 2000-10-16
NO970327D0 (no) 1997-01-24
ZA964091B (en) 1997-01-21
WO1996037498A1 (en) 1996-11-28
MX9601953A (es) 1997-08-30
CA2195578A1 (en) 1996-11-28
ES2097093B1 (es) 1998-01-16
IL118280A (en) 1999-10-28
AU698455B2 (en) 1998-10-29
DE69610477T2 (de) 2001-05-10
EP0773947A1 (en) 1997-05-21
DE69610477D1 (de) 2000-11-02

Similar Documents

Publication Publication Date Title
PH22136A (en) Dihydropyridazinone derivatives and use thereof
MXPA02004448A (es) Derivados de imidazopiridina como inhibidores de la fosfodiesterasa vii.
YU75101A (sh) Supstituisani biciklični heterocikli, postupak njihove izrade i njihova upotreba kao antigojaznih i hipoholesterolemijskih agenasa
AU537028B2 (en) Imidazole derivatives
ES8207180A1 (es) Procedimiento de fabricacion de derivados de tetrahidro-5,67,7a 4h-tieno (3,2-c) piridinona-2 .
NZ515407A (en) 4-Phenyl-pyrimidine derivatives
ATE37872T1 (de) Phenylinden-derivate, ihre salze, und verfahren zu ihrer herstellung.
DE3477782D1 (en) Imidazo(1,2-c)pyrimidines and their salts, process for their preparation, their use as medicaments and compositions containing them
MXPA04002838A (es) Derivados de alquilaminopiridazinona sustituidos, procedimiento para la preparacion de los mismos y composiciones farmaceuticas que los contienen.
HRP20000027B1 (en) Process for the preparation of alkoxyfuranoneamine derivatives, compounds obtained by this process, and the use of these compounds
ATE269329T1 (de) Neue basische derivate von benz(e)isoindol-1-onen und pyrrolo(3,4-c)chinolin-1-onen mit 5-ht3- antagonistischer aktivität, ihre herstellung und ihre therapeutische verwendung
TW430666B (en) New 5H-thiazolo[3,2-a]pyrimidin-5-one derivatives
GR3034226T3 (en) 4-p-fluorobenzoyl-1-piperidinyl-propoxy-chromen-4-one derivatives, their preparation and their use in the treatment of psychosis and schizophrenia
CA2192596A1 (en) 4-(6-fluoro-1,2-benzisoxazolyl)-1-piperidinyl-propoxy-chromen-4-one derivatives, their preparation and their use in the treatment of psychosis, schizophrenia and anxiety
DE3065469D1 (en) Triazolo (4,3-a)pyridin-3(2h)-ones, process for their preparation and pharmaceutical compositions containing them
IE832466L (en) Indoles and intermediates.
FR2626279B1 (fr) Nouveaux derives de l'indolo(3,2,1-de)(1,4)-oxazino(2,3,4-ij)(1,5) naphthyridine, leur procede de preparation et les nouveaux intermediaires ainsi obtenus, leur application comme medicaments et les compositions les renfermant
TW288015B (en) New chromene derivatives
TW353071B (en) Chromene compounds with neutroleptic activity, their preparation and pharmaceutical compositions

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19970316

Kind code of ref document: A1

Effective date: 19970316